Boardroom Alpha
Boardroom Alpha
DOW · Additional Proxy Materials (DEFA14A) · Filed March 17, 2026

Dow Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 17, 2026
Ticker
DOW
Accession
0001193125-26-110874
Boardroom Alpha · Filing insights

Dow Inc. seeks approval of an amended 2019 Stock Incentive Plan to increase share availability. The Board supports the amendment.

About Dow Inc
Market cap
$25.0B
1Y TSR
+37.0%
3Y TSR
−5.5%
Board grade
C-
Sector
Basic Materials
CEO
Karen S Carter
Last annual meeting: Apr 9, 2026 · View full Dow Inc profile →
DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.  )

 

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

 

Preliminary Proxy Statement

 

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

 

Definitive Proxy Statement

 

 

Definitive Additional Materials

 

 

Soliciting Material under §240.14a-12

 

img199631155_0.jpg

Dow Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

 

No fee required

 

 

Fee paid previously with preliminary materials

 

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 


gfx199631155_0.gif

 

img199631155_1.jpg

 

 

YOUR VOTE IS IMPORTANT

PLEASE VOTE YOUR PROXY TODAY

 

 

 

March 17, 2026

 

Dear Fellow Stockholders,

 

We recently distributed proxy materials of Dow Inc. (“Dow”) in connection with the 2026 Annual Meeting of Stockholders to be held on April 9, 2026. Your vote and your support are important at this year’s meeting.

 

We want to highlight a specific agenda item for this year’s Annual Meeting. In addition to requesting your support for the election of our directors, say on pay, one year for frequency of say on pay, and the ratification of our auditor appointment, we ask for your support to vote FOR Agenda Item 4, the Amendment to the 2019 Stock Incentive Plan (“SIP”). Your attention to this proposal is appreciated.

 

Dow requests that stockholders approve the Amendment to the SIP as adopted by the Board on February 12, 2026 (the “Amendment”) in accordance with the recommendation of the Board’s Compensation and Leadership Development Committee. Approval of the Amendment will allow us to successfully compete for employee talent over the next few years and meet our future needs to attract, motivate and retain key members of our workforce to support the execution of our business strategy with the goal of enabling greater shareholder returns.

 

The Amendment provides for an increase in the number of shares available for issuance under the SIP. This request is intended to cover the anticipated share usage for at least the next three years which aligns with peer practices, where large S&P 500 companies typically seek shareholder approval for additional shares every three to five years. The resulting annual dilution (burn rate) from our grants over the past three years has averaged below 1% per year.

 

The Board of Directors recommends a vote FOR the election of all of our directors, FOR the say on pay proposal, 1 YEAR for the say on frequency of say on pay proposal, FOR the ratification of our auditor appointment and FOR the Amendment to our 2019 Stock Incentive Plan.

 

We encourage you to carefully review the Proxy Statement dated February 27, 2026 for more details on our 2026 Annual Meeting agenda.

 

On behalf of your Board of Directors, thank you for your cooperation and continued support. We appreciate your vote.

 

Sincerely,

img199631155_2.jpg

Jim Fitterling

Chair and Chief Executive Officer

 

Midland, Michigan USA


 

 

Dow Inc.

Letter to Stockholders

March 17, 2026

Page 2

 

 

Voting is easy—have your control number ready and either call the number or go online to follow the instructions on the proxy card or the voting instruction form. You can also vote by mailing your completed proxy card or the voting instruction form in the pre-paid envelope provided.

 

If you hold shares in multiple accounts, please vote each proxy card and voting instruction form you receive to ensure that all your shares are represented at the 2026 Annual Meeting.

 

Please vote. Your vote is important no matter how many shares you hold.

 

 

2026 Annual Meeting of Stockholders

Agenda Item

Board Vote

Recommendation

1:

Election of Directors

FOR

2:

Advisory Resolution to Approve Executive Compensation

(Say on Pay)

FOR

3:

Advisory Resolution on the Frequency of Future Advisory Votes to Approve Executive Compensation (Frequency of Say on Pay)

1 YEAR

4:

Approval of the Amendment to the 2019 Stock Incentive Plan

FOR

5:

Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for 2026

FOR

 

 

If you have any questions or need assistance voting your shares,

please call our proxy solicitor, D.F. King & Co., Inc., toll-free at 1-866-342-4884.

 

 

 


From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Dow Inc (DOW)

Reference

Frequently asked questions

When did Dow Inc file this DEFA14A?
Dow Inc (DOW) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 17, 2026. The accession number assigned by EDGAR is 0001193125-26-110874.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Dow Inc. seeks approval of an amended 2019 Stock Incentive Plan to increase share availability. The Board supports the amendment. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Dow Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Dow Inc has filed under CIK 1751788, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer